Nemiralisib in Patients with an Acute Exacerbation of COPD: Placebo-Controlled, Dose-Ranging Study

BACKGROUND: Management of acute exacerbations of chronic obstructive pulmonary disease (COPD) is sometimes inadequate leading to either prolonged duration and/or an increased risk of recurrent exacerbations in the period following the initial event. OBJECTIVE: To evaluate the safety and efficacy of...

Descripción completa

Detalles Bibliográficos
Autores principales: Fahy, William A, Homayoun-Valiani, Farshid, Cahn, Anthony, Robertson, Jon, Templeton, Alison, Meeraus, Wilhelmine H, Wilson, Robert, Lowings, Mike, Marotti, Miriam, West, Sarah L, Tabberer, Maggie, Hessel, Edith M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184152/
https://www.ncbi.nlm.nih.gov/pubmed/34113095
http://dx.doi.org/10.2147/COPD.S309320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184152/
https://www.ncbi.nlm.nih.gov/pubmed/34113095
http://dx.doi.org/10.2147/COPD.S309320

Ejemplares similares